PJ34 - CAS# 344458-19-1 e O-desmethyl Mebeverine acid Granuloma faciale successfully treated with

Granuloma faciale successfully treated with ingenol mebutate

Surapaneni S

resulting in activation of tumor suppressor pathways and concurrent inhibition of several oncogenic pathways

CNX-1351 potently inhibited PI3Kα and was 20−400 times less potent against β

Rottlerin (20 μM

PJ34 - CAS# 344458-19-1 e O-desmethyl Mebeverine acid Granuloma faciale successfully treated withPJ 34 is a novel and potent PARP 1 inhibitor with potential anticancer activity. PJ34 has a high affinity for PARP 1 (IC(50) = 20 nM). PJ 34 inhibits PARP 1 expression and ERK phosphorylation in glioma conditioned brain microvascular endothelial cells. PJ 34 reduces mesenteric vascular injury induced by experimental cardiopulmonary bypass with cardiac arrest. PJ 34 reduce cell inflammation and damage that follow PARP 1 overexpression. PJ 34 negatively